APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-Drug-Eluting Devices

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Non-Drug-Eluting Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025190 pages

Choose your research edition.

Industry ResearchNon-Drug-Eluting Devices Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Drug-Eluting Devices Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Non-Drug-Eluting Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Drug-Eluting Devices Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Drug-Eluting Devices Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Non-Drug-Eluting Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Non-Drug-Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-Drug-Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Drug-Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Non-Drug-Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-Drug-Eluting Devices include Teleflex Incorporated, Johnson & Johnson, Medtronic, Boston Scientific Corporation, B. Braun Melsungen AG, Stryker Corporation, Smith & Nephew plc., Peter Surgical and Integra Lifesciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-Drug-Eluting Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-Drug-Eluting Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-Drug-Eluting Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-Drug-Eluting Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-Drug-Eluting Devices Segment by Company

Teleflex Incorporated

Johnson & Johnson

Medtronic

Boston Scientific Corporation

B. Braun Melsungen AG

Stryker Corporation

Smith & Nephew plc.

Peter Surgical

Integra Lifesciences

DemeTECH Corporation

ConMed Corporation

Non-Drug-Eluting Devices Segment by Type

Implants

Sutures

Non-Drug-Eluting Devices Segment by Application

Hospital

Ambulatory Surgical Centers

Non-Drug-Eluting Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Drug-Eluting Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Drug-Eluting Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Drug-Eluting Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-Drug-Eluting Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-Drug-Eluting Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Non-Drug-Eluting Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Non-Drug-Eluting Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Non-Drug-Eluting Devices Industry Trends Table 2. Non-Drug-Eluting Devices Industry Drivers Table 3. Non-Drug-Eluting Devices Industry Opportunities and Challenges Table 4. Non-Drug-Eluting Devices Industry Restraints Table 5. Global Non-Drug-Eluting Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Non-Drug-Eluting Devices Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Non-Drug-Eluting Devices Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Non-Drug-Eluting Devices Sales Market Share by Manufacturers Table 9. Global Non-Drug-Eluting Devices Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Non-Drug-Eluting Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Non-Drug-Eluting Devices Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Non-Drug-Eluting Devices Manufacturers, Product Type & Application Table 13. Global Non-Drug-Eluting Devices Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-Drug-Eluting Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Implants Table 17. Major Manufacturers of Sutures Table 18. Global Non-Drug-Eluting Devices Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Non-Drug-Eluting Devices Sales by Type (2021-2026) & (K Units) Table 20. Global Non-Drug-Eluting Devices Sales by Type (2027-2032) & (K Units) Table 21. Global Non-Drug-Eluting Devices Sales Market Share by Type (2021-2026) Table 22. Global Non-Drug-Eluting Devices Sales Market Share by Type (2027-2032) Table 23. Global Non-Drug-Eluting Devices Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Non-Drug-Eluting Devices Revenue by Type (2021-2026) & (K Units) Table 25. Global Non-Drug-Eluting Devices Revenue by Type (2027-2032) & (K Units) Table 26. Global Non-Drug-Eluting Devices Revenue Market Share by Type (2021-2026) Table 27. Global Non-Drug-Eluting Devices Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Ambulatory Surgical Centers Table 30. Global Non-Drug-Eluting Devices Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Non-Drug-Eluting Devices Sales by Application (2021-2026) & (K Units) Table 32. Global Non-Drug-Eluting Devices Sales by Application (2027-2032) & (K Units) Table 33. Global Non-Drug-Eluting Devices Sales Market Share by Application (2021-2026) Table 34. Global Non-Drug-Eluting Devices Sales Market Share by Application (2027-2032) Table 35. Global Non-Drug-Eluting Devices Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Non-Drug-Eluting Devices Revenue by Application (2021-2026) & (K Units) Table 37. Global Non-Drug-Eluting Devices Revenue by Application (2027-2032) & (K Units) Table 38. Global Non-Drug-Eluting Devices Revenue Market Share by Application (2021-2026) Table 39. Global Non-Drug-Eluting Devices Revenue Market Share by Application (2027-2032) Table 40. Global Non-Drug-Eluting Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Non-Drug-Eluting Devices Sales by Region (2021-2026) & (K Units) Table 42. Global Non-Drug-Eluting Devices Sales Market Share by Region (2021-2026) Table 43. Global Non-Drug-Eluting Devices Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Non-Drug-Eluting Devices Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Non-Drug-Eluting Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Non-Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 47. North America Non-Drug-Eluting Devices Sales by Country (2027-2032) & (K Units) Table 48. Europe Non-Drug-Eluting Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Non-Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 50. Europe Non-Drug-Eluting Devices Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Non-Drug-Eluting Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Non-Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Non-Drug-Eluting Devices Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Non-Drug-Eluting Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Non-Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Non-Drug-Eluting Devices Sales by Country (2027-2032) & (K Units) Table 57. Global Non-Drug-Eluting Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Non-Drug-Eluting Devices Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Non-Drug-Eluting Devices Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Non-Drug-Eluting Devices Revenue Market Share by Region (2021-2026) Table 61. Global Non-Drug-Eluting Devices Revenue Market Share by Region (2027-2032) Table 62. Teleflex Incorporated Company Information Table 63. Teleflex Incorporated Business Overview Table 64. Teleflex Incorporated Non-Drug-Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Teleflex Incorporated Non-Drug-Eluting Devices Product Portfolio Table 66. Teleflex Incorporated Recent Development Table 67. Johnson & Johnson Company Information Table 68. Johnson & Johnson Business Overview Table 69. Johnson & Johnson Non-Drug-Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Johnson & Johnson Non-Drug-Eluting Devices Product Portfolio Table 71. Johnson & Johnson Recent Development Table 72. Medtronic Company Information Table 73. Medtronic Business Overview Table 74. Medtronic Non-Drug-Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Medtronic Non-Drug-Eluting Devices Product Portfolio Table 76. Medtronic Recent Development Table 77. Boston Scientific Corporation Company Information Table 78. Boston Scientific Corporation Business Overview Table 79. Boston Scientific Corporation Non-Drug-Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Boston Scientific Corporation Non-Drug-Eluting Devices Product Portfolio Table 81. Boston Scientific Corporation Recent Development Table 82. B. Braun Melsungen AG Company Information Table 83. B. Braun Melsungen AG Business Overview Table 84. B. Braun Melsungen AG Non-Drug-Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. B. Braun Melsungen AG Non-Drug-Eluting Devices Product Portfolio Table 86. B. Braun Melsungen AG Recent Development Table 87. Stryker Corporation Company Information Table 88. Stryker Corporation Business Overview Table 89. Stryker Corporation Non-Drug-Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Stryker Corporation Non-Drug-Eluting Devices Product Portfolio Table 91. Stryker Corporation Recent Development Table 92. Smith & Nephew plc. Company Information Table 93. Smith & Nephew plc. Business Overview Table 94. Smith & Nephew plc. Non-Drug-Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Smith & Nephew plc. Non-Drug-Eluting Devices Product Portfolio Table 96. Smith & Nephew plc. Recent Development Table 97. Peter Surgical Company Information Table 98. Peter Surgical Business Overview Table 99. Peter Surgical Non-Drug-Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Peter Surgical Non-Drug-Eluting Devices Product Portfolio Table 101. Peter Surgical Recent Development Table 102. Integra Lifesciences Company Information Table 103. Integra Lifesciences Business Overview Table 104. Integra Lifesciences Non-Drug-Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Integra Lifesciences Non-Drug-Eluting Devices Product Portfolio Table 106. Integra Lifesciences Recent Development Table 107. DemeTECH Corporation Company Information Table 108. DemeTECH Corporation Business Overview Table 109. DemeTECH Corporation Non-Drug-Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. DemeTECH Corporation Non-Drug-Eluting Devices Product Portfolio Table 111. DemeTECH Corporation Recent Development Table 112. ConMed Corporation Company Information Table 113. ConMed Corporation Business Overview Table 114. ConMed Corporation Non-Drug-Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. ConMed Corporation Non-Drug-Eluting Devices Product Portfolio Table 116. ConMed Corporation Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Non-Drug-Eluting Devices Distributors List Table 120. Non-Drug-Eluting Devices Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Non-Drug-Eluting Devices Product Image Figure 2. Global Non-Drug-Eluting Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Drug-Eluting Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-Drug-Eluting Devices Sales (2021-2032) & (K Units) Figure 5. Global Non-Drug-Eluting Devices Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Non-Drug-Eluting Devices Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Implants Image Figure 9. Sutures Image Figure 10. Global Non-Drug-Eluting Devices Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Non-Drug-Eluting Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Non-Drug-Eluting Devices Sales Market Share by Type (2021-2032) Figure 13. Global Non-Drug-Eluting Devices Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Non-Drug-Eluting Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Non-Drug-Eluting Devices Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Ambulatory Surgical Centers Image Figure 18. Global Non-Drug-Eluting Devices Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Non-Drug-Eluting Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Non-Drug-Eluting Devices Sales Market Share by Application (2021-2032) Figure 21. Global Non-Drug-Eluting Devices Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Non-Drug-Eluting Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Non-Drug-Eluting Devices Revenue Market Share by Application (2021-2032) Figure 24. North America Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Non-Drug-Eluting Devices Sales Market Share by Country (2021-2032) Figure 26. U.S. Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Non-Drug-Eluting Devices Sales Market Share by Country (2021-2032) Figure 31. Germany Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Non-Drug-Eluting Devices Sales Market Share by Country (2021-2032) Figure 38. China Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Non-Drug-Eluting Devices Sales Market Share by Country (2021-2032) Figure 46. Brazil Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Non-Drug-Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Non-Drug-Eluting Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Non-Drug-Eluting Devices Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Non-Drug-Eluting Devices Revenue (2021-2032) & (US$ Million) Figure 57. North America Non-Drug-Eluting Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Non-Drug-Eluting Devices Revenue (2021-2032) & (US$ Million) Figure 59. Europe Non-Drug-Eluting Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Non-Drug-Eluting Devices Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Non-Drug-Eluting Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Non-Drug-Eluting Devices Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Non-Drug-Eluting Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Non-Drug-Eluting Devices Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Non-Drug-Eluting Devices Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Implants
  • Sutures
Applications
  • Hospital
  • Ambulatory Surgical Centers
Companies covered
  • Teleflex Incorporated
  • Johnson & Johnson
  • Medtronic
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Stryker Corporation
  • Smith & Nephew plc.
  • Peter Surgical
  • Integra Lifesciences
  • DemeTECH Corporation
  • ConMed Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-Drug-Eluting Devices Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-Drug-Eluting Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Non-Drug-Eluting Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Non-Drug-Eluting Devices Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Non-Drug-Eluting Devices Market Dynamics
  1. 2.1 Non-Drug-Eluting Devices Industry Trends
  2. 2.2 Non-Drug-Eluting Devices Industry Drivers
  3. 2.3 Non-Drug-Eluting Devices Industry Opportunities and Challenges
  4. 2.4 Non-Drug-Eluting Devices Industry Restraints
3 Non-Drug-Eluting Devices Market by Manufacturers
  1. 3.1 Global Non-Drug-Eluting Devices Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Non-Drug-Eluting Devices Sales by Manufacturers (2021-2026)
  3. 3.3 Global Non-Drug-Eluting Devices Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Non-Drug-Eluting Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-Drug-Eluting Devices Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Non-Drug-Eluting Devices Manufacturers, Product Type & Application
  7. 3.7 Global Non-Drug-Eluting Devices Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-Drug-Eluting Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-Drug-Eluting Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-Drug-Eluting Devices Tier 1, Tier 2, and Tier 3
4 Non-Drug-Eluting Devices Market by Type
  1. 4.1 Non-Drug-Eluting Devices Type Introduction
  2. 4.1.1 Implants
  3. 4.1.2 Sutures
  4. 4.2 Global Non-Drug-Eluting Devices Sales by Type
  5. 4.2.1 Global Non-Drug-Eluting Devices Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Non-Drug-Eluting Devices Sales by Type (2021-2032)
  7. 4.2.3 Global Non-Drug-Eluting Devices Sales Market Share by Type (2021-2032)
  8. 4.3 Global Non-Drug-Eluting Devices Revenue by Type
  9. 4.3.1 Global Non-Drug-Eluting Devices Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Non-Drug-Eluting Devices Revenue by Type (2021-2032)
  11. 4.3.3 Global Non-Drug-Eluting Devices Revenue Market Share by Type (2021-2032)
5 Non-Drug-Eluting Devices Market by Application
  1. 5.1 Non-Drug-Eluting Devices Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Ambulatory Surgical Centers
  4. 5.2 Global Non-Drug-Eluting Devices Sales by Application
  5. 5.2.1 Global Non-Drug-Eluting Devices Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Non-Drug-Eluting Devices Sales by Application (2021-2032)
  7. 5.2.3 Global Non-Drug-Eluting Devices Sales Market Share by Application (2021-2032)
  8. 5.3 Global Non-Drug-Eluting Devices Revenue by Application
  9. 5.3.1 Global Non-Drug-Eluting Devices Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Non-Drug-Eluting Devices Revenue by Application (2021-2032)
  11. 5.3.3 Global Non-Drug-Eluting Devices Revenue Market Share by Application (2021-2032)
6 Global Non-Drug-Eluting Devices Sales by Region
  1. 6.1 Global Non-Drug-Eluting Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-Drug-Eluting Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Non-Drug-Eluting Devices Sales by Region (2021-2026)
  4. 6.2.2 Global Non-Drug-Eluting Devices Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-Drug-Eluting Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Non-Drug-Eluting Devices Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Non-Drug-Eluting Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Non-Drug-Eluting Devices Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Non-Drug-Eluting Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Non-Drug-Eluting Devices Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Non-Drug-Eluting Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Non-Drug-Eluting Devices Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Non-Drug-Eluting Devices Revenue by Region
  1. 7.1 Global Non-Drug-Eluting Devices Revenue by Region
  2. 7.1.1 Global Non-Drug-Eluting Devices Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Non-Drug-Eluting Devices Revenue by Region (2021-2026)
  4. 7.1.3 Global Non-Drug-Eluting Devices Revenue by Region (2027-2032)
  5. 7.1.4 Global Non-Drug-Eluting Devices Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Non-Drug-Eluting Devices Revenue (2021-2032)
  8. 7.2.2 North America Non-Drug-Eluting Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Non-Drug-Eluting Devices Revenue (2021-2032)
  11. 7.3.2 Europe Non-Drug-Eluting Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Non-Drug-Eluting Devices Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Non-Drug-Eluting Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Non-Drug-Eluting Devices Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Non-Drug-Eluting Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teleflex Incorporated
  2. 8.1.1 Teleflex Incorporated Company Information
  3. 8.1.2 Teleflex Incorporated Business Overview
  4. 8.1.3 Teleflex Incorporated Non-Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teleflex Incorporated Non-Drug-Eluting Devices Product Portfolio
  6. 8.1.5 Teleflex Incorporated Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Non-Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Non-Drug-Eluting Devices Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Non-Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Non-Drug-Eluting Devices Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
  19. 8.4 Boston Scientific Corporation
  20. 8.4.1 Boston Scientific Corporation Company Information
  21. 8.4.2 Boston Scientific Corporation Business Overview
  22. 8.4.3 Boston Scientific Corporation Non-Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Boston Scientific Corporation Non-Drug-Eluting Devices Product Portfolio
  24. 8.4.5 Boston Scientific Corporation Recent Developments
  25. 8.5 B. Braun Melsungen AG
  26. 8.5.1 B. Braun Melsungen AG Company Information
  27. 8.5.2 B. Braun Melsungen AG Business Overview
  28. 8.5.3 B. Braun Melsungen AG Non-Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 B. Braun Melsungen AG Non-Drug-Eluting Devices Product Portfolio
  30. 8.5.5 B. Braun Melsungen AG Recent Developments
  31. 8.6 Stryker Corporation
  32. 8.6.1 Stryker Corporation Company Information
  33. 8.6.2 Stryker Corporation Business Overview
  34. 8.6.3 Stryker Corporation Non-Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Stryker Corporation Non-Drug-Eluting Devices Product Portfolio
  36. 8.6.5 Stryker Corporation Recent Developments
  37. 8.7 Smith & Nephew plc.
  38. 8.7.1 Smith & Nephew plc. Company Information
  39. 8.7.2 Smith & Nephew plc. Business Overview
  40. 8.7.3 Smith & Nephew plc. Non-Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Smith & Nephew plc. Non-Drug-Eluting Devices Product Portfolio
  42. 8.7.5 Smith & Nephew plc. Recent Developments
  43. 8.8 Peter Surgical
  44. 8.8.1 Peter Surgical Company Information
  45. 8.8.2 Peter Surgical Business Overview
  46. 8.8.3 Peter Surgical Non-Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Peter Surgical Non-Drug-Eluting Devices Product Portfolio
  48. 8.8.5 Peter Surgical Recent Developments
  49. 8.9 Integra Lifesciences
  50. 8.9.1 Integra Lifesciences Company Information
  51. 8.9.2 Integra Lifesciences Business Overview
  52. 8.9.3 Integra Lifesciences Non-Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Integra Lifesciences Non-Drug-Eluting Devices Product Portfolio
  54. 8.9.5 Integra Lifesciences Recent Developments
  55. 8.10 DemeTECH Corporation
  56. 8.10.1 DemeTECH Corporation Company Information
  57. 8.10.2 DemeTECH Corporation Business Overview
  58. 8.10.3 DemeTECH Corporation Non-Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 DemeTECH Corporation Non-Drug-Eluting Devices Product Portfolio
  60. 8.10.5 DemeTECH Corporation Recent Developments
  61. 8.11 ConMed Corporation
  62. 8.11.1 ConMed Corporation Company Information
  63. 8.11.2 ConMed Corporation Business Overview
  64. 8.11.3 ConMed Corporation Non-Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ConMed Corporation Non-Drug-Eluting Devices Product Portfolio
  66. 8.11.5 ConMed Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-Drug-Eluting Devices Value Chain Analysis
  2. 9.1.1 Non-Drug-Eluting Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-Drug-Eluting Devices Production Mode & Process
  6. 9.2 Non-Drug-Eluting Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-Drug-Eluting Devices Distributors
  9. 9.2.3 Non-Drug-Eluting Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst